Institut d'Investigacions Biomèdiques August Pi i Sunyer-ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2024

  1. Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis

    Therapeutic Advances in Psychopharmacology, Vol. 14

  2. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

    Spanish Journal of Psychiatry and Mental Health

2023

  1. Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism

    Neuropsychopharmacology, Vol. 48, Núm. 2, pp. 341-350

  2. The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features

    Biomedicines, Vol. 11, Núm. 2

2022

  1. NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

2021

  1. Identification of bip as a cb1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain

    Journal of Neuroscience, Vol. 41, Núm. 38, pp. 7924-7941

2020

  1. Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort

    Arthritis and Rheumatology, Vol. 72, Núm. 10, pp. 1734-1740

  2. Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index

    Arthritis and Rheumatology, Vol. 72, Núm. 4, pp. 658-666

2019

  1. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794

  2. Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 92-105

  3. Osteopontin and disease activity in patients with recent-onset systemic Lupus Erythematosus: Results from the SLICC Inception Cohort

    Journal of Rheumatology, Vol. 46, Núm. 5, pp. 492-500

  4. Selective Knockdown of TASK3 Potassium Channel in Monoamine Neurons: a New Therapeutic Approach for Depression

    Molecular Neurobiology, Vol. 56, Núm. 4, pp. 3038-3052

2018

  1. Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 5, pp. 441-455

  2. Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 268, Núm. 7, pp. 699-711

2017

  1. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

    Schizophrenia Research, Vol. 189, pp. 84-90

2016

  1. Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia

    Journal of Psychiatry and Neuroscience, Vol. 41, Núm. 3, pp. E46-E55

  2. Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies

    Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 4, pp. 391-399

  3. Off-label use of rituximab for systemic lupus erythematosus in Europe

    Lupus Science and Medicine, Vol. 3, Núm. 1

2015

  1. Mood disorders in systemic lupus erythematosus: Results from an international inception cohort study

    Arthritis and Rheumatology, Vol. 67, Núm. 7, pp. 1837-1847

2013

  1. Belimumab en el lupus eritematoso sistémico: una guía para su uso en la práctica diaria

    Revista Clinica Espanola